Price to Book Value Chart

View Price to Book Value for HITI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
August 28, 2026 3.386
August 27, 2026 3.467
August 26, 2026 3.400
August 25, 2026 3.467
August 24, 2026 3.319
August 21, 2026 3.305
August 20, 2026 3.305
August 19, 2026 3.319
August 18, 2026 3.238
August 17, 2026 3.143
August 14, 2026 3.170
August 13, 2026 3.130
August 12, 2026 3.143
August 11, 2026 3.157
August 10, 2026 3.103
August 07, 2026 3.103
August 06, 2026 3.089
August 05, 2026 3.062
August 04, 2026 3.035
August 03, 2026 2.900
July 31, 2026 2.860
July 30, 2026 2.887
July 29, 2026 2.766
July 28, 2026 2.779
July 27, 2026 2.873
Date Value
July 24, 2026 2.900
July 23, 2026 2.900
July 22, 2026 2.900
July 21, 2026 2.968
July 20, 2026 2.914
July 17, 2026 3.022
July 16, 2026 2.873
July 15, 2026 2.927
July 14, 2026 2.914
July 13, 2026 2.941
July 10, 2026 2.981
July 09, 2026 2.981
July 08, 2026 3.008
July 07, 2026 3.022
July 06, 2026 3.062
July 02, 2026 3.103
July 01, 2026 3.143
June 30, 2026 3.076
June 29, 2026 3.076
June 26, 2026 3.022
June 25, 2026 2.968
June 24, 2026 2.981
June 23, 2026 2.995
June 22, 2026 3.089
June 18, 2026 3.116

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Tilray Brands, Inc. 0.3727
cbdMD, Inc. 0.6771
CannaPharmaRx, Inc. --
Cosmos Health, Inc. 0.8768
Lexaria Bioscience Corp. 3.610

Price to Book Value Related Metrics

PS Ratio 0.4536
PEG Ratio -0.0214
Price to Free Cash Flow 20.32
Price 2.51
Earnings Yield -14.45%
Market Cap 220.55M
PEGY Ratio -0.0214
Operating PE Ratio 12.81